Attention deficit-hyperactivity disorder symptoms in women with polycystic ovary syndrome
Objectives
Several studies suggest that androgens are involved in the etiology of attention deficit-hyperactivity disorder (ADHD). In this study, we investigated the ADHD symptoms in women with polycystic ovary syndrome (PCOS), a complex endocrine, hormonal, and metabolic condition associated with hyperandrogenism.
Methods
Forty women between the ages of 18 and 35 years with PCOS were recruited for the study group. For comparison, 40 healthy women who had regular menses were included. Current and childhood ADHD symptoms were assessed by using the Adult ADHD Self-Report Scale and Wender-Utah Rating Scale, respectively.
Results
Women with PCOS had higher total Adult ADHD Self-Report Scale and total Wender-Utah Rating Scale scores than controls. According to the Wender-Utah Rating Scale, the frequency of childhood ADHD was significantly higher in PCOS group than the control. Adult ADHD Self-Report Scale: Hyperactivity–Impulsivity and Wender-Utah Rating Scale: Behavioral Problems/Impulsivity scores were significantly higher in women with PCOS. However, there were no significant differences between groups in both current and childhood inattention scores. We found no correlations between ADHD symptoms and serum hormone levels including testosterone in women with PCOS.
Conclusions
These results suggest that women with PCOS have higher ADHD symptoms. Further studies are needed to investigate the association between PCOS and ADHD.
Top-30
Journals
|
1
2
|
|
|
Psychoneuroendocrinology
2 publications, 8.7%
|
|
|
Journal of Clinical Endocrinology and Metabolism
1 publication, 4.35%
|
|
|
Endocrine Reviews
1 publication, 4.35%
|
|
|
Current Opinion in Obstetrics and Gynecology
1 publication, 4.35%
|
|
|
Toxics
1 publication, 4.35%
|
|
|
Current Psychiatry Reports
1 publication, 4.35%
|
|
|
Current Diabetes Reports
1 publication, 4.35%
|
|
|
JAMA network open
1 publication, 4.35%
|
|
|
Biological Psychiatry
1 publication, 4.35%
|
|
|
Progress in Neuro-Psychopharmacology and Biological Psychiatry
1 publication, 4.35%
|
|
|
Metabolites
1 publication, 4.35%
|
|
|
Psychological Medicine
1 publication, 4.35%
|
|
|
International Journal of Gynecology and Obstetrics
1 publication, 4.35%
|
|
|
European Child and Adolescent Psychiatry
1 publication, 4.35%
|
|
|
Journal of Eating Disorders
1 publication, 4.35%
|
|
|
Frontiers in Global Women s Health
1 publication, 4.35%
|
|
|
Journal of Attention Disorders
1 publication, 4.35%
|
|
|
Medicine (United States)
1 publication, 4.35%
|
|
|
1
2
|
Publishers
|
1
2
3
4
5
|
|
|
Springer Nature
5 publications, 21.74%
|
|
|
Elsevier
5 publications, 21.74%
|
|
|
The Endocrine Society
2 publications, 8.7%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
2 publications, 8.7%
|
|
|
MDPI
2 publications, 8.7%
|
|
|
American Medical Association (AMA)
1 publication, 4.35%
|
|
|
Cambridge University Press
1 publication, 4.35%
|
|
|
Wiley
1 publication, 4.35%
|
|
|
Frontiers Media S.A.
1 publication, 4.35%
|
|
|
SAGE
1 publication, 4.35%
|
|
|
1
2
3
4
5
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.